Fifty-one patients were randomly assigned to receive either a single 2.5-mg intra-amniotic injection of ( 15S ) -15 - methyl-prostaglandin F ( 2 ) ( alpha ) ( n = 26 ) or two 200-microg intravaginal doses of misoprostol ( n = 25 ) at 12-hour intervals .
